{
    "clinical_study": {
        "@rank": "4692", 
        "arm_group": [
            {
                "arm_group_label": "Yili Lactoferrin ShuHua Milk (lactoferrin 5mg/100ml)", 
                "arm_group_type": "Active Comparator", 
                "description": "Total 250mL milk (with lactoferrin 5mg/100ml) will be taken once per day at 10am daily during the 84 days intervention."
            }, 
            {
                "arm_group_label": "Yili Lactoferrin ShuHua Milk (lactoferrin 10mg/100ml)", 
                "arm_group_type": "Active Comparator", 
                "description": "Total 250mL milk (with lactoferrin 10mg/100ml) will be taken once per day at 10am daily during the 84 days intervention."
            }, 
            {
                "arm_group_label": "Recombined low-protein milk", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Total 250mL placebo milk will be taken once per day at 10am daily during the 84 days intervention."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine whether Yili Lactoferrin ShuHua Milk are effective\n      in reducing the occurrence of flu symptoms."
        }, 
        "brief_title": "Study of Yili Lactoferrin ShuHua Milk in the Improvement of Human Immunization", 
        "completion_date": {
            "#text": "October 2011", 
            "@type": "Actual"
        }, 
        "condition": [
            "Immunization", 
            "Human Influenza", 
            "Common Cold"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Common Cold", 
                "Influenza, Human"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age 6 to 12 years, catch cold for 4 to 6 times in last year;\n\n          -  Age 35 to 45 years, catch cold for 4 to 6 times in recent 3 month;\n\n          -  Age 60 to 75 years, catch cold for 4 to 6 times in last year;\n\n          -  BMI 18.5to 29.9kg/m2;\n\n          -  Able to understand the nature and purpose of the study including potential risks and\n             side effects\n\n        Exclusion Criteria:\n\n          -  Recent (within 6 months of screening) been vaccinated influenza vaccine, or recent\n             (within 15 days of screening) been vaccinated ther vaccines;\n\n          -  Suffering from rhinitis chronic, laryngitis, labored breathing that similar to flu\n             symptoms. Such as chronic allergic rhinitis, asthma, COPD;\n\n          -  Long-term use of any prescription or OTC medication that inhibit or prevent flu\n             symptoms, including but not limited to, antihistamine,  pectoral, high doses of\n             vitamin C;\n\n          -  Recent use (within 3 months of screening) of any prescription or OTC medication that\n             significantly affects immune response, such as antibiotic;\n\n          -  Known allergies to dairy and any substance in the study product;\n\n          -  History of alcohol, drug, or medication abuse\n\n          -  Pregnant or breastfeeding women\n\n          -  Recent daily use (within 3 months of screening) of any probiotics, clabber or yogurt;\n\n          -  Any comorbidity that could, in the opinion of the investigator, preclude the\n             subject's ability to successfully and safely complete the study or that may confound\n             study outcomes"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "75 Years", 
            "minimum_age": "6 Years"
        }, 
        "enrollment": {
            "#text": "240", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "August 23, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01677702", 
            "org_study_id": "YL/CL-002"
        }, 
        "intervention": [
            {
                "arm_group_label": "Yili Lactoferrin ShuHua Milk (lactoferrin 5mg/100ml)", 
                "description": "Total 250mL milk (with lactoferrin 5mg/100ml) will be taken once per day at 10am daily during the 84 days intervention.", 
                "intervention_name": "Yili Lactoferrin ShuHua Milk (Lactoferrin 5mg/100ml)", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Yili Lactoferrin ShuHua Milk (lactoferrin 10mg/100ml)", 
                "description": "Total 250mL milk (with lactoferrin 10mg/100ml) will be taken once per day at 10am daily during the 84 days intervention.", 
                "intervention_name": "Yili Lactoferrin ShuHua Milk (Lactoferrin 10mg/100ml)", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Recombined low-protein milk", 
                "description": "Total 250ml of placebo milk will be taken once a day at 10am daily during the 84 day intervention.", 
                "intervention_name": "Recombined low protein milk", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "October 24, 2012", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Chao Yang District", 
                        "country": "China", 
                        "state": "Beijing"
                    }, 
                    "name": "NanMoFang Community Health Service Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "GuCun, Baoshan District,", 
                        "country": "China", 
                        "state": "Shanghai"
                    }, 
                    "name": "JuQuan Community Health Service Center"
                }
            }
        ], 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "3", 
        "official_title": "The Clinical Research on the Efficiency of Yili Lactoferrin Shuhua Milk in the Improvement of Human Immunization", 
        "overall_official": [
            {
                "affiliation": "Inner Mongolia Hilo Industrial Group Co., Ltd", 
                "last_name": "Ying An, Ph.D", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "Changhai Hospital of Shanghai, Nutriology Dept.", 
                "last_name": "Donglian Cai", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Changhai Hospital of Shanghai, Rheumatology Dept.", 
                "last_name": "Yeqing Shi", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "China: Ethics Committee"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Assess occurrence of flu symptoms during intervention", 
            "safety_issue": "No", 
            "time_frame": "3 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01677702"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Assess severity of flu symptoms", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "measure": "Proportion of subjects which require treatment with flu medication", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "measure": "Change in immune markers such as antibodies and interleukins", 
                "safety_issue": "No", 
                "time_frame": "Baseline & 3 months"
            }, 
            {
                "measure": "Record subject sick leave due to flu", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }
        ], 
        "source": "Inner Mongolia Yili Industrial Group Co., Ltd", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Inner Mongolia Yili Industrial Group Co., Ltd", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "March 2011", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "October 2012"
    }
}